阿司匹林通过抑制垂体腺瘤中的PTTG1介导其抗肿瘤效应
研究在RC-4B/C和GH3垂体细胞系中探讨阿司匹林对DNA甲基化组和转录组的影响,并在41例人垂体神经内分泌肿瘤(PitNET)样本及基因表达综合数据库(GEO)的76例PitNET与34例对照数据中评估PTTG1表达。阿司匹林诱导全基因组DNA去甲基化、增加5hmC、通过p53乙酰化增强Tp53活性并下调Pttg1启动子活性,伴随细胞增殖和迁移减少。作者认为阿司匹林在PitNET中可能具有潜在益处。
要点
- 阿司匹林在垂体细胞系中诱导全基因组DNA去甲基化并改变转录组。
- 阿司匹林通过p53乙酰化增强Tp53活性并抑制Pttg1启动子活性。
- 5hmC与Tet1-3和Tp53表达正相关、与Pttg1表达负相关。
核心结论
- 阿司匹林调控全基因组去甲基化、Tp53活性和Pttg1表达,并伴随细胞增殖和迁移减少。
- 5hmC作为PitNET的新型组织生物标志物,在体外也指示阿司匹林的抗肿瘤效应。
- 作者认为阿司匹林在PitNET中可能具有潜在有益效应。
研究设计与样本
- 在RC-4B/C和GH3垂体细胞系中,给予阿司匹林处理后检测DNA甲基化组和全转录组谱。
- 体外进一步测试阿司匹林与去甲基化剂地西他滨的效应。
- 评估41例人PitNET样本中PTTG1表达,以及基因表达综合数据库(GEO)中76例PitNET和34例对照样本的全基因组基因和蛋白表达数据。
主要发现
- 阿司匹林诱导全基因组DNA去甲基化及随之的转录组改变。
- Tet酶及其辅因子Uhrf2过表达被确定为5-羟甲基胞嘧啶(5hmC)增加的原因。
- 阿司匹林通过p53乙酰化增加Tp53活性并降低E2f1活性。
- 在p53调控基因中,阿司匹林通过抑制Pttg1启动子活性下调Pttg1及其相互作用伙伴。
- 5hmC与Tet1-3和Tp53表达正相关,与Pttg1表达负相关,地西他滨的效应强化了这一关系。
关键数值与推荐
- 阿司匹林调控基因与PitNET组织失调基因的重叠为20.15%。
- 5hmC与Tet1-3和Tp53表达正相关,与Pttg1表达负相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: DNA demethylation and inhibitory effects of aspirin on pituitary cell proliferation have been demonstrated. OBJECTIVE: Our aim was to clarify the molecular mechanisms behind the aspirin-related effects in pituitary cells. METHODS: DNA methylome and whole transcriptome profile were investigated in RC-4B/C and GH3 pituitary cell lines upon aspirin treatment. Effects of aspirin and a demethylation agent, decitabine, were further tested in vitro. PTTG1 expression in 41 human PitNET samples and whole genome gene and protein expression data of 76 PitNET and 34 control samples (available in Gene Expression Omnibus) were evaluated. RESULTS: Aspirin induced global DNA demethylation and consequential transcriptome changes. Overexpression of Tet enzymes and their cofactor Uhrf2 were identified behind the increase of 5-hydroxymethylcytosine (5hmC). Besides cell cycle, proliferation, and migration effects that were validated by functional experiments, aspirin increased Tp53 activity through p53 acetylation and decreased E2f1 activity. Among the p53 controlled genes, Pttg1 and its interacting partners were downregulated upon aspirin treatment by inhibiting Pttg1 promoter activity. 5hmC positively correlated with Tet1-3 and Tp53 expression, and negatively correlated with Pttg1 expression, which was reinforced by the effect of decitabine. Additionally, high overlap (20.15%) was found between aspirin-regulated genes and dysregulated genes in PitNET tissue samples. CONCLUSION: A novel regulatory network has been revealed, in which aspirin regulated global demethylation, Tp53 activity, and Pttg1 expression along with decreased cell proliferation and migration. 5hmC, a novel tissue biomarker in PitNET, indicated aspirin antitumoral effect in vitro as well. Our findings suggest the potential beneficial effect of aspirin in PitNET.
引用
- Szabó B, Németh K, Mészáros K, et al. Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma. J Clin Endocrinol Metab. 2022. PMID: 36059148. doi:10.1210/clinem/dgac496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。